Education
About Us
Working with TipRanks
Follow Us
WIN-Partners Co., Ltd. (JP:3183)
:3183
3183 Stock Chart & Stats
¥1326.00
-¥7.00(-0.53%)
At close: 4:00 PM EST
¥1326.00
-¥7.00(-0.53%)
Day’s Range― - ―
52-Week Range¥1,125.00 - ¥1,595.00
Previous CloseN/A
Volume13.40K
Average Volume (3M)11.73K
Market Cap
¥41.40B
Enterprise Value¥25.16B
Total Cash (Recent Filing)¥16.83B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)18.1
Beta0.70
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.97%
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,503,310
10 Day Avg. Volume13,600
30 Day Avg. Volume11,726
Financial Highlights & Ratios
PEG Ratio2.00
Price to Book (P/B)1.58
Price to Sales (P/S)0.47
P/FCF Ratio23.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetZero reported debt materially reduces financial risk and interest-rate sensitivity, giving the company durable flexibility. A debt-free structure supports reliable capital allocation choices, preserves dividend capacity and enables opportunistic investments or M&A without raising leverage over the medium term.
Consistent Profitability & MarginsStable gross (~12%) and net margins (~2.4%–2.9%) reflect reliable distributor economics and operational control. Persistent margins support predictable earnings and cash flow, enabling steady reinvestment into the business, employee retention, and a sustained dividend policy across business cycles.
Rising Equity And Solid ROERising equity combined with consistent ROE (high-single-digits to ~9%) indicates the company is growing its capital base while generating reasonable returns. This balance enhances funding optionality from internal capital, underpins long-term shareholder value creation and reduces reliance on external debt.
Bears Say
Recent Revenue ContractionTop-line turned slightly negative in 2025 after prior expansion, which risks undermining operating leverage and future margin expansion. Persistent or recurring revenue weakness would limit internal funding for growth initiatives, constrain hiring and investments, and reduce long-term earnings visibility.
Volatile Free Cash FlowFree cash flow has been swingy—negative in 2022–2023 then rebounding—signaling sensitivity to working capital and timing. That volatility reduces predictability for capex, dividends and strategic spending, forcing management to maintain larger liquidity buffers and potentially curtail growth investments in weak periods.
Uneven Asset Growth / Working-capital SwingsAssets dipped in 2024–2025 relative to 2023, implying working-capital or investment swings that impair forecasting. Such variability can strain short-term liquidity, create periodic pressure on cash conversion and complicate planning for inventory, supplier terms and client billing cycles over the medium term.
WIN-Partners Co., Ltd. News
3183 FAQ
What was WIN-Partners Co., Ltd.’s price range in the past 12 months?
WIN-Partners Co., Ltd. lowest stock price was ¥1125.00 and its highest was ¥1595.00 in the past 12 months.
What is WIN-Partners Co., Ltd.’s market cap?
WIN-Partners Co., Ltd.’s market cap is ¥41.40B.
When is WIN-Partners Co., Ltd.’s upcoming earnings report date?
WIN-Partners Co., Ltd.’s upcoming earnings report date is Aug 10, 2026 which is in 156 days.
How were WIN-Partners Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is WIN-Partners Co., Ltd. overvalued?
According to Wall Street analysts WIN-Partners Co., Ltd.’s price is currently Overvalued.
Does WIN-Partners Co., Ltd. pay dividends?
WIN-Partners Co., Ltd. pays a Annually dividend of ¥53 which represents an annual dividend yield of 3.97%. See more information on WIN-Partners Co., Ltd. dividends here
What is WIN-Partners Co., Ltd.’s EPS estimate?
WIN-Partners Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does WIN-Partners Co., Ltd. have?
WIN-Partners Co., Ltd. has 30,503,310 shares outstanding.
What happened to WIN-Partners Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of WIN-Partners Co., Ltd.?
Currently, no hedge funds are holding shares in JP:3183
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
WIN-Partners Co., Ltd.
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring and magnetic resonance imaging equipment. The company was founded in 1973 and is headquartered in Tokyo, Japan.
Technical Analysis
Medley
―
Saint-Care Holding Corp.
―
Japan Hospice Holdings Inc.
―
Amvis Holdings.Inc.
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---